| Literature DB >> 27413740 |
Zübeyir Huyut1, Mehmet Ramazan Şekeroğlu1, Ragıp Balahoroğlu1, Tahsin Karakoyun1, Erdem Çokluk1.
Abstract
It has been reported that many modifications occur with the increase of oxidative stress during storage in erythrocytes. In order to delay these negative changes, we evaluated whether the addition of substances likely to protect antioxidant capacity in stored blood would be useful. Therefore, we investigated the effects of resveratrol, tannic acid, and caffeic acid in lipid peroxidation and antioxidant capacity of erythrocytes in stored blood. Donated blood was taken into four CPD containing blood bags. One bag was used as the control, and the others were supplemented with caffeic acid (30 μg/mL), resveratrol (30 μg/mL), and tannic acid (15 μg/mL), respectively. Erythrocyte lipid peroxidation, sensitivity to oxidation, glutathione levels and carbonic anhydrase, glutathione peroxidase, and catalase activities were measured on days 0, 7, 14, 21, and 28. In the control group, erythrocyte malondialdehyde levels and sensitivity to oxidation were increased whereas glutathione, glutathione peroxidase, and catalase levels were decreased (p < 0.05). Resveratrol and caffeic acid prevented malondialdehyde accumulation and preserved glutathione, glutathione peroxidase, and catalase activities in erythrocytes. We demonstrated that resveratrol, caffeic acid, and tannic acid in stored blood could decrease the sensitivity to oxidation of erythrocytes in vitro but did not exhibit such effects on CA activity.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27413740 PMCID: PMC4931059 DOI: 10.1155/2016/3057384
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
The inhibition effects of caffeic acid, resveratrol, and tannic acid on erythrocyte MDA levels in stored whole blood time-dependently.
| MDA (nmol/gHb) | ||||
|---|---|---|---|---|
| Control | Caffeic acid | Resveratrol | Tannic acid | |
| Baseline (time 0) | 22.33 ± 6.37 | 21.28 ± 5.13 | 21.97 ± 8.08 | 21.29 ± 6.49 |
| 7th day | 35.70 ± 2.89҂ | 29.64 ± 1.67 | 31.09 ± 4.79 | 31.43 ± 3.01 |
| 14th day | 37.36 ± 5.28҂ | 32.20 ± 2.76 | 36.91 ± 1.98 | 37.68 ± 5.20҂ |
| 21st day | 39.94 ± 6.95҂ | 33.86 ± 2.91 | 40.26 ± 4.92 | 44.41 ± 6.02 |
| 28th day | 46.04 ± 9.87҂ | 38.51 ± 1.53 | 45.87 ± 5.54 | 46.13 ± 6.76҂ |
Significant differences (p < 0.05) between the control and treated groups are indicated by ∗.
Significant differences (p < 0.05) between the control and resveratrol and tannic acid are indicated by ∗∗.
Significant differences (p < 0.05) in each group from time 0 (baseline) are given by ҂.
The inhibition effects of caffeic acid, resveratrol, and tannic acid on erythrocyte MDA levels after the two-hour incubation with the solution of H2O2 (sensitivity to oxidation of RBC).
| 2-hour MDA (nmol/gHb) | ||||
|---|---|---|---|---|
| Control | Caffeic acid | Resveratrol | Tannic acid | |
| Baseline | 101.96 ± 9.14 | 103.56 ± 14.40 | 107.96 ± 9.14 | 108.81 ± 11.38 |
| 7th day | 274.75 ± 21.93҂ | 309.19 ± 28.20 | 221.28 ± 15.69҂ | 267.93 ± 24.71 |
| 14th day | 397.54 ± 23.38҂ | 390.10 ± 32.71҂ | 298.09 ± 29.89҂ | 421.70 ± 27.15 |
| 21st day | 437.84 ± 19.96҂ | 407.85 ± 38.35 | 314.02 ± 18.41 | 433.26 ± 18.82҂ |
| 28th day | 499.69 ± 12.60҂ | 411.51 ± 20.15 | 338.85 ± 15.83 | 441.73 ± 20.17҂ |
Significant differences (p < 0.05) between the control and treated groups are indicated by ∗.
Significant differences (p < 0.05) between the control and caffeic acid and tannic acid are indicated by ∗∗.
Significant differences (p < 0.05) in each group from time 0 (baseline) are given by ҂.
The protective effects of caffeic acid, resveratrol, and tannic acid on catalase activity of RBC in stored whole blood time-dependently.
| Catalase (kU/gHb) | ||||
|---|---|---|---|---|
| Control | Caffeic acid | Resveratrol | Tannic acid | |
| Baseline | 17.47 ± 2.12 | 17.96 ± 4.49 | 18.02 ± 6.76 | 19.12 ± 1.53 |
| 7th day | 16.52 ± 3.04 | 30.12 ± 9.97 | 38.64 ± 11.32 | 19.52 ± 3.36 |
| 14th day | 14.45 ± 1.56 | 40.94 ± 5.33 | 40.96 ± 5.97 | 20.26 ± 2.99 |
| 21st day | 12.70 ± 1.51 | 56.22 ± 8.42 | 50.15 ± 13.57 | 20.89 ± 2.08 |
| 28th day | 9.16 ± 1.52҂ | 48.84 ± 11.62 | 47.57 ± 7.32 | 20.47 ± 1.73 |
Significant differences (p < 0.05) between the control and treated groups are indicated by ∗.
Significant differences (p < 0.05) between the control and resveratrol and tannic acid are indicated by ∗∗.
Significant differences (p < 0.05) in each group from time 0 (baseline) are given by ҂.
The protective effects of caffeic acid, resveratrol, and tannic acid on the GSH levels of RBC in stored whole blood time-dependently.
| GSH (mg/gHb) | ||||
|---|---|---|---|---|
| Control | Caffeic acid | Resveratrol | Tannic acid | |
| Baseline | 10.72 ± 0.68 | 9.80 ± 2.44 | 9.94 ± 0.69 | 10.34 ± 1.59 |
| 7th day | 10.51 ± 1.15 | 10.96 ± 1.52 | 12.86 ± 1.20҂ | 10.27 ± 1.20 |
| 14th day | 10.36 ± 0.63 | 10.61 ± 0.72 | 14.09 ± 1.76 | 11.00 ± 1.75 |
| 21st day | 8.53 ± 1.94҂ | 12.52 ± 2.29 | 12.46 ± 0.91 | 10.71 ± 1.44 |
| 28th day | 7.96 ± 0.59҂ | 12.32 ± 1.54 | 12.67 ± 0.52 | 10.57 ± 1.31 |
Significant differences (p < 0.05) between the control and treated groups are indicated by ∗.
Significant differences (p < 0.05) between the control and tannic acid are indicated by ∗∗.
Significant differences (p < 0.05) in each group from time 0 (baseline) are given by ҂.
The protective effects of caffeic acid, resveratrol, and tannic acid on GSH-Px activity of RBC in stored whole blood time-dependently.
| GSH-Px (IU/gHb) | ||||
|---|---|---|---|---|
| Control | Caffeic acid | Resveratrol | Tannic acid | |
| Baseline | 50.35 ± 2.38 | 48.92 ± 3.73 | 49.14 ± 2.81 | 50.29 ± 4.24 |
| 7th day | 45.47 ± 2.89҂ | 50.93 ± 3.36 | 52.09 ± 2.25 | 50.82 ± 1.81 |
| 14th day | 42.79 ± 2.59҂ | 53.07 ± 2.87 | 53.43 ± 2.61 | 51.38 ± 1.93 |
| 21st day | 37.05 ± 2.04҂ | 51.20 ± 3.26 | 50.35 ± 2.32 | 49.76 ± 1.51 |
| 28th day | 28.69 ± 3.91҂ | 46.65 ± 3.03 | 48.90 ± 2.38 | 45.30 ± 1.74 |
Significant differences (p < 0.05) between the control and treated groups are indicated by ∗.
Significant differences (p < 0.05) in each group from time 0 (baseline) are given by ҂.
The protective effects of caffeic acid, resveratrol, and tannic acid on carbonic anhydrase activity of RBC in stored whole blood time-dependently.
| Carbonic anhydrase activity (IU/gHb) | ||||
|---|---|---|---|---|
| Control | Caffeic acid | Resveratrol | Tannic acid | |
| Baseline | 37447.05 ± 6610.71 | 35459.50 ± 6875.23 | 33061.22 ± 3328.76 | 39592.14 ± 4641.80 |
| 7th day | 35759.53 ± 5841.47 | 40489.28 ± 5857.81 | 40213.21 ± 7552.89҂ | 43124.78 ± 11072.50 |
| 14th day | 34881.80 ± 6910.69 | 44055.82 ± 10547.32 | 46072.18 ± 11850.02 | 43289.98 ± 7619.90 |
| 21st day | 34822.20 ± 2570.16 | 47601.52 ± 16160.80 | 36897.59 ± 4755.26 | 38277.01 ± 6653.30 |
| 28th day | 33714.45 ± 4760.06 | 40182.18 ± 6503.96 | 36858.38 ± 5734.33 | 37319.28 ± 4357.00 |
Significant differences (p < 0.05) between the control and treated groups are indicated by ∗.
Significant differences (p < 0.05) between the control and resveratrol and tannic acid are indicated by ∗∗.
Significant differences (p < 0.05) in each group from time 0 (baseline) are given by ҂.